Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Björn E. Wahlin
M7‐FLIPI Is Not Prognostic in Follicular Lymphoma Patients With First‐line Rituximab Chemo‐free Therapy
British Journal of Haematology
Hematology
Perturbations of the Endocannabinoid System in Mantle Cell Lymphoma: Correlations to Clinical and Pathological Features
Oncoscience
Cancer Research
Oncology
Related publications
Management of Patients With Follicular Lymphoma Treated First Line With Obinutuzumab
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Characteristics and Outcomes of Patients With Relapsed Follicular Lymphoma Following Retreatment With Second-Line Rituximab-Containing Chemotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Prognostic Value of Flipi in the Era of Rituximab
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prognostic Value of Pre-Treatment Pet Scan in Patients With Follicular Lymphoma Receiving Frontline Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Do We Need Maintenance With Anti-Cd20 Antibody After First-Line Therapy for All Newly Diagnosed Follicular Lymphoma Patients?
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Prognostic Factors in Follicular Lymphoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Retrospective Study on the Management of Patients With Rituximab Refractory Follicular Lymphoma
British Journal of Haematology
Hematology
Maintenance Rituximab Is Associated With Improved Overall Survival in Mantle Cell Lymphoma Patients Responding to Induction Therapy With Bendamustine + Rituximab (Br)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma
British Journal of Haematology
Hematology
